facebook tracking

Ovarian Cancer Free Patient Webinar Header

Know What Your Doctors Know: Ovarian Cancer

Experts provide information and answer questions on ovarian cancer, treatment options, recent advances in care, and supportive care resources.

Click the play button above to view the Know What Your Doctors Know: Ovarian Cancer videos playlist or select an individual video within the playlist menu in the top left corner of the video window or from the list below.

View the full video of the webinar.

Part 1 – About NCCN and NCCN Foundation

Part 2 – Presenters

Part 3 – Genetic Testing

Part 4 – Surgery

Part 5 – HIPEC

Part 6 – Advances in Treatment

Part 7 – Clinical Trials

Part 8 – Resources

Part 9 – Closing

Q&A – Benefits of PARP Inhibitors

Q&A – Breast Cancer Drugs

Q&A – CA125 After Chemo

Q&A – CA125 Test

Q&A – Carbo-Taxol

Q&A – Dietary Changes

Q&A – Genetic Mutations

Q&A – Housekeeping and Guidelines Update

Q&A – IV and IP Chemo in Seniors

Q&A – Limit of Chemotherapy in a Lifetime

Q&A – Low-Resource Countries

Q&A – Neuropathy Prevention

Q&A – PARP Inhibitor Study

Q&A – PARP Inhibitors in Combination with Chemo

Q&A – Patients Advocating for Research

Q&A – Platinum Resistant Patients

Q&A – Recruiting Minority Patients for Clinical Trials

Q&A – Relationship with Estrogen and Ovarian Cancer

Q&A – Research and Screening for Early Diagnosis

Q&A – Research Targeting Stem Cells

Q&A – Side Effects of PARP Inhibitors

Q&A – Standard of Maintenance of High-Grade Ovarian Cancer

Q&A – Tumor Testing

Q&A – Virotherapy

The Know What Your Doctors Know: Ovarian Cancer webinars occurred in February 2020. This informational program was created in conjunction with the recently updated NCCN Guidelines for Patients® for Ovarian Cancer.

The NCCN Guidelines for Patients sheets are available to read and download for free online and via the NCCN Patient Guides for Cancer mobile app. Printed editions can be ordered from Amazon.com for a small fee.

NCCN Guidelines for Patients DO NOT replace the expertise and clinical judgment of the clinician.


This activity is supported through the NCCN Foundation, by a contribution from our industry supporter AstraZeneca. NCCN independently develops and distributes the NCCN Guidelines for Patients. Our industry supporters do not participate in the development of the NCCN Guidelines for Patients and are not responsible for the content and recommendations contained therein.

The NCCN Guidelines for Patients: Ovarian Cancer are supported by National Ovarian Cancer Coalition (NOCC) and endorsed by Ovarcome; FORCE: Facing Our Risk of Cancer Empowered; Sharsheret; Ovarian Cancer Research Alliance (OCRA); Ovarian & Breast Cancer Alliance of Washington State